Evidence for a newly discovered cellular anti-HIV-1 phenotype (original) (raw)

• Steeves, R. & Lilly, F. Interactions between host and viral genomes in mouse leukemia. Ann. Rev. Genet. 11, 277–296 (1977).
  Article CAS PubMed Google Scholar
• Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).
  Article CAS PubMed Google Scholar
• Samson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
  Article CAS PubMed Google Scholar
• Smith, M. et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959–965 (1997).
  Article CAS PubMed Google Scholar
• Winkler, C. et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279, 389– 393 (1998).
  Article CAS PubMed Google Scholar
• Simon, J. H. M. et al. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17, 1259–1267 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Fisher, A. G. et al. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888– 893 (1987).
  Article CAS PubMed Google Scholar
• Strebel, K. et al. The HIV "A" (sor) gene product is essential for virus infectivity. Nature 328, 728– 730 (1987).
  Article CAS PubMed Google Scholar
• Gabuzda, D. H. et al. Role of vif in replication of human immunodeficiency virus type 1 in + T lymphocytes. J. Virol. 66, 6489–6495 (1992).
  CAS PubMed PubMed Central Google Scholar
• von Schwedler, U., Song, J., Aiken, C. & Trono, D. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67, 4945– 4955 (1993).
  CAS PubMed PubMed Central Google Scholar
• Tomonaga, K. et al. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66, 6181–6185 (1992).
  CAS PubMed PubMed Central Google Scholar
• Simon, J.H.M., Southerling, T.E., Peterson, J.C., Meyer, B.E. & Malim, M.H. Complementation of _vif_-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69, 4166– 4172 (1995).
  CAS PubMed PubMed Central Google Scholar
• Reddy, T.R. et al. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. J. Virol. 69, 3549–3553 (1995).
  CAS PubMed PubMed Central Google Scholar
• Harmache, A. et al. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 224, 246–255 (1996).
  Article CAS PubMed Google Scholar
• Desrosiers, R. C. et al. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72, 1431– 1437 (1998).
  CAS PubMed PubMed Central Google Scholar
• Fan, L. & Peden, K. Cell-free transmission of Vif mutants of HIV-1. Virology 190, 19– 29 (1992).
  Article CAS PubMed Google Scholar
• Sakai, H. et al. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67, 1663–1666 (1993).
  CAS PubMed PubMed Central Google Scholar
• Sova, P. & Volsky, D.J. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with _vif_-negative human immunodeficiency virus type 1. J. Virol. 67, 6322–6326 (1993).
  CAS PubMed PubMed Central Google Scholar
• Simon, J.H.M. & Malim, M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70, 5297– 5305 (1996).
  CAS PubMed PubMed Central Google Scholar
• Fouchier, R.A.M., Simon, J.H.M., Jaffe, A.B. & Malim, M.H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of _gag_-, _pol_- and _env_-encoded proteins. J. Virol. 70, 8263–8269 (1996).
  CAS PubMed PubMed Central Google Scholar
• Bouyac, M. et al. Phenotypically Vif– human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J. Virol. 71, 2473–2477 (1997).
  CAS PubMed PubMed Central Google Scholar
• Mèvel-Ninio, M. & Weiss, M.C. Immunofluorescence analysis of the time-course of extinction, reexpression, and activation of albumin production in rat hepatoma-mouse fibroblast heterokaryons and hybrids. J. Cell. Biol. 90, 339– 350 (1981).
  Article PubMed Google Scholar
• Beggs, A.H., Frisque, R.J. & Scangos, G.A. Extinction of JC virus tumor-antigen expression in glial cell-fibroblast hybrids. Proc. Natl. Acad. Sci. USA 85, 7632–7636 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Goncalves, J., Korin, Y., Zack, J. & Gabuzda, D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 8701–8709 (1996).
  CAS PubMed PubMed Central Google Scholar
• Simon, J.H.M. et al. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71, 5259–5267 (1997).
  CAS PubMed PubMed Central Google Scholar
• Marrack, P. & Kappler, J. Subversion of the immune system by pathogens. Cell 76, 323– 332 (1994).
  Article CAS PubMed Google Scholar
• Smith, G.L. Virus proteins that bind cytokines, chemokines or interferons. Curr. Opin. Immunol. 8, 467–471 (1996).
  Article CAS PubMed Google Scholar
• Ploegh, H.L. Viral strategies of immune evasion. Science 280, 248–253 (1998).
  Article CAS PubMed Google Scholar
• Moss, B. in Fields Virology (eds Fields, B.N., Knipe, D.M. & Howley, P.M.) 2637–2671 (Lippincott-Raven, Philadelphia, 1996).
  Google Scholar
• Bertin, J. et al. Death effector domain-containing herpes-virus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172–1176 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, S., Vincenz, C., Buller, M. & Dixit, V.M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621–9624 (1997).
  Article CAS PubMed Google Scholar
• Thome, M. et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517– 521 (1997).
  Article CAS PubMed Google Scholar
• Katze, M.G. Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3, 75–78 (1995).
  Article CAS PubMed Google Scholar
• Mathews, M.B. Structure, function and evolution of adenovirus virus-associated RNAs. Curr. Top. Microbiol. Immunol. 199, 173– 187 (1995).
  CAS PubMed Google Scholar
• Best, S., Le Tissier, P., Towers, G. & Stoye, J.P. Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826–829 (1996).
  Article CAS PubMed Google Scholar
• DesGroseillers, L. & Jolicoeur, P. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685–696 (1983).
  CAS PubMed PubMed Central Google Scholar
• Dubay, J.W., Roberts, S.J., Hahn, B.H. & Hunter, E. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6616–6625 (1992).
  CAS PubMed PubMed Central Google Scholar
• Felber, B.K. & Pavlakis, G.N. A quantitative bioassay for HIV-1 based on trans-activation. Science 239, 184–187 (1988).
  Article CAS PubMed Google Scholar